POWER1 Study Recruitment Is Now Complete.
POWER1 Study Update
Praxis is excited to share that recruitment for the POWER1 study is now complete. We are incredibly grateful to every participant who helped us move one step closer to advancing a potential new treatment option for adults living with focal epilepsy.
Recruitment is now open for the POWER2 study. If you are an adult living with focal epilepsy and are interested in joining a clinical trial, we invite you to learn more.
Click here to explore details about the POWER2 study and see if it may be a good fit for you
POWER2 Study
About the POWER1 Study
The POWER1 study is a clinical research study evaluating a new investigational medicine called vormatrigine. The goal of the study is to understand how well vormatrigine works to reduce focal onset seizures compared to a placebo, as well as to evaluate its safety and potential side effects.
About Vormatrigine
Vormatrigine is a once-daily investigational medicine being studied for its potential to help people manage focal onset seizures. Researchers hope that it may offer improved seizure control with fewer side effects, providing better day-to-day support for individuals living with focal epilepsy.
POWER1 study Recruitment Is Now Complete.
POWER1 Study Update
Praxis is excited to share that recruitment for the POWER1 study is now complete. We are incredibly grateful to every participant who helped us move one step closer to advancing a potential new treatment option for adults living with focal epilepsy.
Recruitment is now open for the POWER2 study. If you are an adult living with focal epilepsy and are interested in joining a clinical trial, we invite you to learn more.
Click here to explore details about the POWER2 study and see if it may be a good fit for you
POWER2 Study About the POWER1 Study
The POWER1 study is a clinical research study evaluating a new investigational medicine called vormatrigine. The goal of the study is to understand how well vormatrigine works to reduce focal onset seizures compared to a placebo, as well as to evaluate its safety and potential side effects.
About Vormatrigine
Vormatrigine is a once-daily investigational medicine being studied for its potential to help people manage focal onset seizures. Researchers hope that it may offer improved seizure control with fewer side effects, providing better day-to-day support for individuals living with focal epilepsy.